Skip to main content
Equibles

COHANCE · Cohance Lifesciences Limited · Financials

Use COHANCE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research COHANCE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
458.60 INR -13.05 (-2.77%) At close · Nov 13
Rebalance outlook locked
Market Cap
175.46B INR
Shares
382.60M
Volume · Nov 13 432.05K Avg daily vol (3M) 1.03M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
22.69B +89.4%
FY2026 Revenue FY2020–FY2026
Net Income
1.79B -33.1%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
3.68B +27.8%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2023 FY2022 FY2021 FY2020
INR 20.63B 22.69B 11.98B 13.4B 13.2B 10.1B 8.34B
INR 1.98B 1.87B 774.9M 477.32M 390.97M 316.36M 238.6M
INR 334.1M 372.4M 123.5M 54.36M 62.31M 91.44M 230.66M
INR 68.9M 2.07B 3.44B 5.6B — — —
INR 124.8M 569.2M 791.5M 1.48B 2.14B 1.05B 875.1M
INR 473.7M 1.79B 2.68B 4.11B 0 3.62B 3.17B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 3.05B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.